Keyword: Oligonucleotides


EuroAPI Completes Acquisition of BianoGMP

22.11.2023 -

EuroAPI has completed the acquisition of BianoGMP, a contract development and manufacturing organization (CDMO) specializing in oligonucleotides.


EuroAPI to Acquire German CDMO BianoGMP

29.08.2023 -

Active pharmaceutical ingredients manufacturer EuroAPI has agreed to acquire BianoGMP, a contract development and manufacturing organization (CDMO) specializing in...


Bachem Inks $531 Million Peptides Manufacturing Deal

08.03.2023 -

Bachem, a Swiss specialist developer and manufacturer of peptides and oligonucleotides, has signed another order worth more than 500 million Swiss francs – or $531...


Agilent Contracts Turner for Frederick API Project

15.02.2023 -

Agilent Technologies has selected Turner Construction to build its previously announced new API plant in Frederick, Colorado, USA. The project is scheduled for completion...


GSK and Wave Life Sciences Partner on Genetics

19.12.2022 -

British pharma GSK has entered into a four-year collaboration with US clinical-stage genetic medicines company Wave Life Sciences to advance oligonucleotide therapeutics...

Research & Innovation

Bachem Innovates its Manufacturing Capabilities

14.10.2022 -

Interest in oligonucleotide therapeutics has grown, as has the market demand, since their emergence as a new drug modality two decades ago.

Chemistry & Life Sciences

Ensuring API Supply Capacities for Europe and Beyond

13.10.2022 -

Interview with Karl Rotthier, CEO of the Sanofi spin-off EuroAPI.


Bachem Buys DSM’s Sisslerfeld Site

10.10.2022 -

Swiss peptide and oligonucleotide specialist Bachem has agreed to buy an undeveloped site in Sisslerfeld from DSM. It has completed the purchase of a first plot, with...